Femtech Startup Tuune Secures $4.6 Million In Financing To Launch In The U.S., Paving The Way For Personalized Birth Control
Femtech Startup Tuune Secures $4.6 Million In Financing To Launch In The U.S., Paving The Way For Personalized Birth Control
10/06/21, 1:00 PM
Location
londonMoney raised
$4.6 million
Round Type
seed
Tuune, a femtech startup revolutionizing women’s health by offering individualized hormonal analysis and birth control, today announced the closing of a $4.6M fundraising round to launch in the U.S. market. The investment, led by venture capital firm Octopus Ventures, will support Tuune’s efforts to build a more individualized medical system that puts hormones first, transforming the future of healthcare for all women and people with cycles.
Company Info
Location
london, ontario, canada
Additional Info
Tuune is a personalized women’s healthcare company, re-inventing the way healthcare accesses the complexity of female hormones with a focus on individuality. Our mission is to make female hormones a pillar of modern holistic healthcare and bridge the gaps in understanding of conditions like PCOS; endometriosis; and cardiometabolic, mental, and bone health. Our first product educates and empowers women to choose the right birth control for their unique hormones and biology.